News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Abbott Matthew S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| Abbott Matthew S (SVP, Chief Enterprise Transfor) has filed a Form 4 on Chemours Co|
Txns:
| Granted 4,069 shares
@ $0 |
|
| 06/09/2023 |
4
| Abbott Matthew S (SVP, Chief Enterprise Transfor) has filed a Form 4 on Chemours Co|
Txns:
| Sold 8,912 shares
@ $34.2, valued at
$304.8k
Exercised 8,912 options to buy
@ $14.43, valued at
$128.6k
|
|
| 05/27/2021 |
4
| Abbott Matthew S (VP, CAO & Controller) has filed a Form 4 on Chemours Co|
Txns:
| Sold 8,913 shares
@ $35.61, valued at
$317.4k
Exercised 8,913 options to buy
@ $14.43, valued at
$128.6k
|
|
| 03/03/2021 |
4
| Abbott Matthew S (VP, CAO & Controller) has filed a Form 4 on Chemours Co|
Txns:
| Paid exercise price by delivering 581 shares
@ $24.01, valued at
$13.9k
Granted 1,249 shares
@ $0
Granted 10,412 shares
@ $0
Granted 12,269 options to buy
@ $24.01, valued at
$294.6k
|
|
| 03/04/2020 |
4
| Abbott Matthew S (VP, CAO & Controller) has filed a Form 4 on Chemours Co|
Txns:
| Granted 17,325 shares
@ $0
Granted 26,737 options to buy
@ $14.43, valued at
$385.8k
|
|
| 03/03/2020 |
4
| Abbott Matthew S (VP, CAO & Controller) has filed a Form 4 on Chemours Co|
Txns:
| Paid exercise price by delivering 857 shares
@ $14.86, valued at
$12.7k
|
|
|
|